The key findings of this study are that treatment with EchA ameliorated renal fibrosis and oxidative stress in db/db mice and enhanced mitochondrial function in diabetic kidneys by inhibiting PKCι/p38 MAPK and activating the AMPK/NRF2/HO-1 pathway. The gene discussed is NFE2L2; the disease is renal fibrosis.